Non–Small Cell Lung Cancer, Version 4.2024
Memorial Sloan Kettering Cancer Center · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · +48 more institutions
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC, including diagnosis, primary disease management, surveillance for relapse, and subsequent treatment. The panel has updated the list of recommended targeted therapies based on recent FDA approvals and clinical data. This selection from the NCCN Guidelines for NSCLC focuses on treatment recommendations for advanced or metastatic NSCLC with actionable molecular biomarkers.
Citation impact
- FWCI
- 249.28
- Percentile
- 100%
- References
- 162
Authors
45- GJGregory J. RielyCorresponding
Memorial Sloan Kettering Cancer Center
- DEDouglas E. Wood
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa, Fred Hutch Cancer Center
- DSDavid S. Ettinger
Sidney Kimmel Comprehensive Cancer Center
- DLDara L. Aisner
University of Colorado Cancer Center, University of Colorado Denver
- WAWallace Akerley
University of Utah, Huntsman Cancer Institute
Topics & keywords
- Medicine
- Lung cancer
- Oncology
- Internal medicine
- Good health and well-being